The mucosal atomization devices are used for the administration of the drugs through nasal, oral, tracheal mucosal surfaces. The tip of the atomizer is very fine which results in a broader coverage of even a thin layer of drug. Due to the advancement in the technology this type of administration is gaining interest and popularity as needles are not used. Moreover it gets directly into the bloodstream and crosses Mucosal membranes easily. The drug through mucosal atomization devices increases its bioavailability while decreasing the onset time. The method is said to be cost effective as it eliminates the intravenous set up time and no pain is felt while administering the drug. The conventional route of administration takes time to reach the targeted area while with the new advancement of devices it has become much easier. The distance of nose or the larynx to the brain leads to an accelerated equilibration and steadiness between the blood and the cerebrospinal fluid and hence the target is achieved at a much faster rate. The rate of delivery of the drug through the Mucosal atomization is superior to subcutaneous and intramuscular routes and equivalent to intravenous administration. The use of mucosal atomization devices is done during pre-hospital and emergency treatments. Also it does not require any sterilisation or invasive equipment such as intravenous catheters and syringes.
Mucosal Atomization devices: Drivers and Restraints
The Major drivers of the Mucosal atomization devices are the increasing prevalence of sinus in many regions. Increasing focus on the disease management with non-invasive and less time consuming treatment methods will lead to increase in the adoption rate of Mucosal atomization devices. Moreover enhancement in the healthcare infrastructure is also playing a role, organisations are collaborating to increase the awareness. The companies are providing technically advanced and efficient products. Launch of novel drugs and therapies with increasing number of regulations for effective and efficient delivery of systems is being carried out. However one has to be very sure of the dosage as it is absorbed in the bloodstream within a very short time and can cause side effects if overdosed. Also during the Mucosal atomization devices protection of delicate organs such as lungs is necessary from hazardous exposures. Also removal of the agent or therapeutic drug is very difficult from the site of administration in case of cold cough or allergies.
Download sample copy of this report:
Mucosal Atomization Devices Market: Segmentation
Tentatively, the global mucosal atomization devices market can be segmented on the basis of product type, sites of delivery and end user
On the basis of product type, the global Mucosal Atomization Devices Market can be segmented into:
On the basis of sites of delivery, the global Mucosal Atomization Devices Market can be segmented into:
Nasal mucosal surface
Oral mucosal surface
Laryngeal mucosal surface
Tracheal mucosal surface
pulmonary mucosal surface
On the basis of end user, the global Mucosal Atomization Devices Market can be segmented into:
Ambulatory Surgical centres
Super Speciality clinics
On the basis of region, the global Mucosal Atomization Devices Market can be segmented into:
Asia Pacific Excluding Japan
Middle East & Africa
Mucosal Atomization Devices Market: Overview
The global market for Mucosal Atomization Devices is expected to witness high growth over the forecast period as the technology does not require the set up for intravenous drug delivery. The target is achieved at a much higher rate. The drug gets directly into the bloodstream and to the target area however one has to be very sure of the dosage as it can cause side effects if over dosed. The market of treatment of mucosal atomization devices is expected to increase with a rise in the patient pool as the treatment is target specific.
Mucosal Atomization Devices Market: Regional Outlook
Geographically, the global mucosal atomization devices market can be segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be a dominant market in the global mucosal atomization devices market, owing to the high prevalence of diseases. Also, the market in North America will rise, due to advancements in technology and strict regulations pertaining to patient care and safety in the region. The mucosal atomization devices market in Asia Pacific excluding Japan is expected to grow with a significant CAGR due to expansion of product offering by key players. In addition, government is making initiatives in the region by providing better healthcare facilities with techniques which require less pain and more efficiency and contribute to the growth of the Mucosal Atomization Devices. Europe is expected to hold the second largest share in the global mucosal atomization devices market throughout the forecast period.
Buy Now to Get 10% Off and Free Customization as per Requirement:
Mucosal Atomization Devices Market: Key Players
The global market for mucosal atomization devices market is highly consolidated. Examples of some of the key players operating in the global mucosal atomization devices market DS Medical, Life-Assist, Inc., Teleflex Medical Europe Ltd, MedTree, Kurve Technology and Wolfetory Medical Inc.among others